Jazz Pharmaceuticals PLC
(NAS:JAZZ)
$
121.59
-1.05 (-0.86%)
Market Cap: 7.35 Bil
Enterprise Value: 10.93 Bil
PE Ratio: 17.13
PB Ratio: 1.76
GF Score: 85/100 Jazz Pharmaceuticals PLC at Barclays Global Healthcare Conference Transcript
Mar 10, 2020 / 01:30PM GMT
Release Date Price:
$112.79
(+2.12%)
Operator
You may begin, sir.
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Good morning, everyone. Thank you for dialing in. My name is Balaji Prasad. I cover specialty pharma for Barclays. Owing to the special circumstances we are in, this is a novel format for us to host a virtual health care conference. So thank you for dialing in.
Continuing with the day's sessions, we have with us today Dan Swisher, President of Jazz Pharmaceuticals; Rob Iannone, EVP, R&D; and Kathee and Diane from the Investor Relations team. Thank you all for dialing in.
Also, owing to the nature of this format, there will be no Q&A session. Rob, Dan, Kathee and Diane, good morning.
Daniel N. Swisher
Jazz Pharmaceuticals plc - President & COO
Good morning.
Katherine A. Littrell
Jazz Pharmaceuticals plc - VP of IR
Good morning.
Robert Iannone
Jazz Pharmaceuticals plc - EVP of Research & Development
Good
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot